NBC 10 Philadelphia
FDA approves first nasal spray to treat dangerous allergic reactions
U.S. health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen. The Food and Drug Administration said it approved the ...
Becker's Hospital Review
‘It’s monumental’: FDA approves 1st OTC naloxone nasal spray
The approval follows an independent panel voting 19-0 in support of allowing for the product that reduces or reverses opioid overdoses to be given the OTC stamp. Northwell Health’s Sandeep Kapoor, MD, ...
News Medical
FDA approves Lannett's ANDA for Sumatriptan Nasal Spray USP
Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal ...
NJBIZ
FDA approves J&J’s Caplyta as add-on depression drug
The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson‘s Caplyta as an add-on treatment for adults with major depressive disorder. Following the FDA’s Nov. 5 decision ...
Medical Xpress
FDA approves Tezspire for chronic rhinosinusitis with nasal polyps
The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...
FiercePharma
FDA approves J&J's Darzalex as 1st treatment for smoldering multiple myeloma
For the first time, patients with abnormal cells detected in their bone marrow have a treatment option before the condition develops into multiple myeloma. The FDA has approved Johnson & Johnson’s ...
Crain's New York Business
Demand for off-label treatment fuels New York’s alternative wellness economy
Add blood plasma replacement to the list of things a well-heeled New Yorker can do with $10,000 and a couple of hours to spare in Midtown Manhattan. The new-age treatment is one of the more expensive ...
WebMD
Tezspire: FDA Approves New Option for Chronic Sinus Inflammation With Nasal Polyps
Tezspire (tezepelumab-ekko) is a prescription medicine used to treat inflammatory conditions of the airways, such as severe asthma. The FDA has now approved it as an add-on treatment for adults and ...
Hosted on MSN
FDA Approves Johnson & Johnson’s TREMFYA for Pediatric Psoriasis and Psoriatic Arthritis
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) announced that the U.S. Food and Drug Administration has approved TREMFYA® (guselkumab) for children six years and older weighing at least 40 kilograms with ...
Seeking Alpha
FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
"For people living with CRSwNP, every breath can feel like a struggle, and many endure years of recurring symptoms and surgeries without significant relief. The approval of TEZSPIRE represents a ...
Nasdaq
FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the ...